An initial spontaneous report from the united states was received via non-med originating from a consumer on (b)(6) 2021 who was a female patient of unknown age who experienced wrong technique in product usage process, product contamination physical, and product delivery mechanism issue following the administration of us refresh contacts 510(k) (carmellose sodium) for "unknown indication".Allergan received the report on 30-sep-2021.Medical history was not reported.Concomitant medications were not reported.No dosage information was reported for us refresh contacts 510(k) (carmellose sodium) (eye drops, solution).The lot number was reported as: t2185 (expiry date: 24-feb-2024).On an unknown date, the patient experienced "black substance released from the bottle" (product contamination physical), "it was clogged" (product delivery mechanism issue), and "pour it into another bottle she had previously finished" (wrong technique in product usage process).This case was considered non-serious.The patient confirmed that the product never dispensed from the bottle or into her eye.She is requesting reimbursement of the product and has the sample available for return.The site of manufacture quality investigation for lot number t2185 has been completed and is within specification.Laboratory tests were not reported.Medical assessment comments: if the event was to recur, it would be likely to result in injury or impairment requiring professional medical intervention to prevent permanent harm or death.
|